Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.85% | 22.12% | 9.46% | -8,345.14% | -97.65% |
| Total Depreciation and Amortization | 10.25% | -4.67% | -1.37% | 7.78% | -3.99% |
| Total Amortization of Deferred Charges | -- | -1.19% | -- | -- | -- |
| Total Other Non-Cash Items | -1.08% | 14.44% | -5.44% | 10.76% | -9.07% |
| Change in Net Operating Assets | 115.49% | -368.10% | 180.26% | -493.23% | 133.02% |
| Cash from Operations | 88.14% | -3,160.16% | 104.39% | -300.75% | 22.30% |
| Capital Expenditure | -31.01% | -9.11% | 20.40% | 17.67% | -17.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -31.01% | -9.11% | 20.40% | 17.67% | -17.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -262.15% | 0.00% | -29.87% | 97.39% | -2,673.91% |
| Issuance of Common Stock | -- | -- | -- | -- | 3,338.19% |
| Repurchase of Common Stock | -8.00% | 16.61% | 21.90% | 64.17% | -45.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.45% | -391.29% | 125.86% | -771.32% | 92.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.86% | -25,248.84% | 100.49% | -455.74% | 718.68% |